Meituan Leads ~USD100m Series C for China’s Qitan Tech
Source(s): DealStreetAsia
Meituan led a CNY700m (~USD100m) Series C for Qitan Tech, a China-based developer of genome sequencing technology, with follow-on from BioTrack Capital and Haoyue Capital. Read more